DF21HZZ
Stereotactic Radiosurgery Gallbladder to None with None, Stereotactic Particulate Radiosurgery Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | 2 Stereotactic Radiosurgery |
| Body Part | 1 Gallbladder |
| Approach | H Stereotactic Particulate Radiosurgery |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Stereotactic radiosurgery to the liver, gallbladder, bile ducts, or pancreas delivers a small number of very high-dose radiation beams that converge precisely on a tumor, sparing the surrounding tissue far more than conventional radiation. It is most often used for liver tumors, including hepatocellular carcinoma and metastases from colorectal or other cancers, in patients who are not surgical candidates because of tumor location, liver function, or overall health. Pancreatic tumors are treated this way less frequently, usually when surgery is not feasible or as an adjunct to chemotherapy.
The treatment is planned around the organ's constant motion from breathing, so imaging and positioning systems track the target between and during sessions. A course typically involves one to five treatments rather than the many weeks required for standard radiation, which shortens recovery time and reduces the burden on patients who are often already managing significant illness.
Because the liver and pancreas sit near the stomach, intestines, and kidneys, planning teams work to limit dose to those structures, and patients may need markers or breath-hold techniques placed beforehand to keep the target steady.
Anatomy & Axis Detail
Gallbladder
Stereotactic radiosurgery directed at the gallbladder is reserved for a very small subset of localized gallbladder cancers, typically when the tumor is confined to the gallbladder fossa and surgery is not an option due to patient factors or anatomic extent. The treatment relies on external imaging to precisely localize the gallbladder, which shifts position with respiration and with the fullness of adjacent bowel, so simulation and immobilization must account for this variability to concentrate the high-dose beams accurately on the organ rather than the neighboring liver or duodenum. Given the anatomic overlap with the liver bed, careful targeting and documentation are needed to confirm that the gallbladder itself, rather than hepatic tissue, is the intended treatment site.
Modality Qualifier: Stereotactic Particulate Radiosurgery
Stereotactic Particulate Radiosurgery refers to single- or limited-fraction radiosurgical treatment delivered with charged particle beams, such as protons, using stereotactic targeting to achieve sharp dose falloff around a small lesion. Its particle physics gives it a different depth-dose profile than the photon-based stereotactic techniques, making it useful when sparing tissue just beyond the target is a priority, unlike Stereotactic Other Photon Radiosurgery or Gamma Beam approaches.
Coding & Documentation
Coders should confirm the documentation explicitly names stereotactic technique (SBRT/SRS, CyberKnife, Gamma Knife-style dose delivery) rather than assuming it from a high-dose regimen described only as "radiation." The operative or treatment note must identify the specific hepatobiliary or pancreatic structure targeted, since the body part value depends on it. A frequent error is coding the number of treatment sessions or fractions as if it changes the root operation; stereotactic radiosurgery is coded the same regardless of how many sessions the course is split into, as long as the technique meets the stereotactic definition. Another common mistake is defaulting to "Other Radiation" when the note actually describes a stereotactic delivery system, or vice versa, coding stereotactic when the therapy was standard fractionated beam radiation. Physician documentation of the qualifier (isodose, if applicable) should also be checked against the radiation oncology report rather than inferred.